Publications by authors named "Dirk Finsinger"

Claim this Profile
T
The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programs.
Herman van Vlijmen, Andrew D Pannifer, Phil Cochrane, Daniel Basting, Volkhart M Li, Dirk Finsinger

Drug Discov Today· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMI European Lead Factory - democratizing access to high-throughput screening.
Philip S Jones, Sylviane Boucharens, Stuart P McElroy, Angus Morrison, Saman Honarnejad, Dirk Finsinger

Nat Rev Drug Discov· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.
Jean Quancard, Anders Bach, Brian Cox, Russell Craft, Dirk Finsinger

ChemMedChem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes.
Jean Quancard, Brian Cox, Dirk Finsinger, Stéphanie M Guéret, Ingo V Hartung

ChemMedChem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel 7-azaindoles as PDK1 inhibitors.
Margarita Wucherer-Plietker, Eugen Merkul, Thomas J J Müller, Christina Esdar, Thorsten Knöchel, Dirk Finsinger

Bioorg Med Chem Lett· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors.
Hans-Peter Buchstaller, Lars Burgdorf, Dirk Finsinger, Frank Stieber, Christian Sirrenberg

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5.
Kai Schiemann, Dirk Finsinger, Frank Zenke, Christiane Amendt, Thorsten Knöchel

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective RGD-Mediated Adhesion of Osteoblasts at Surfaces of Implants.
Martin Kantlehner, Dirk Finsinger, Jörg Meyer, Patricia Schaffner, Alfred Jonczyk

Angew Chem Int Ed Engl· February 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis